Professor Dionysios (Dennis) Douroumis

Health Sciences

Dr. Dionysis (Dennis) Douroumis is a highly distinguished academic leader and researcher serving as a Professor in Pharmaceutical Technology and Process Engineering, as well as the Director of the School of Life and Health Sciences at UNIC Athens, Greece. Renowned for his pioneering work at the intersection of material science and biomedical application, Dr. Douroumis stands at the forefront of modern pharmaceutical innovation, guiding both academic discovery and industrial development.

His cutting-edge research activities are dedicated to exploring and implementing advanced emerging technologies that address critical challenges in medicine. Dr. Douroumis’s research portfolio primarily focuses on three critical pillars:

1. The optimization of continuous manufacturing processes designed to streamline the production and development of next-generation medicinal products.

2. The implementation of advanced 3D printing technologies to design and fabricate novel medical devices, such as transdermal microneedles and bioresorbable tissue engineering scaffolds.

3. The precise synthesis and targeted surface modification of nanomaterials, which hold transformative potential for advanced cancer treatments and localized drug delivery.

An exceptionally collaborative scholar, Dr. Douroumis has cultivated an extensive network of national and international partnerships, working alongside world-class researchers and leading institutions across the globe. His scientific vision is heavily backed by robust funding streams, securing prestigious grants from various European Union (EU) and United Kingdom (UK) frameworks, alongside substantial research investments from global pharmaceutical companies.

Dr. Douroumis’s prolific scientific output includes more than 200 peer-reviewed journal articles, 10 authoritative book chapters, and the successful editing of three comprehensive textbooks. Beyond academic publishing, his innovations have practical, real-world utility, resulting in the generation of more than 10 patent families. Translating his deep technical expertise into corporate and regulatory strategy, he serves as a Chief Scientific Advisor to several prominent pharmaceutical companies, directly steering their research and development (R&D) divisions. Furthermore, his expertise is highly sought after by regulatory bodies, where he regularly acts as an expert evaluator and examiner for competitive European Horizon grant calls.

Throughout his career, Dr. Douroumis has been recognized with numerous accolades celebrating his scientific excellence and professional leadership. He received the prestigious Eminent Fellowship of the Academy of Pharmaceutical Sciences (APS), an honor reserved for individuals demonstrating exceptional leadership, advocacy, and sustained excellence in the field over a prolonged period. Additionally, his contributions to chemical and pharmaceutical engineering have been recognized with multiple awards from both the American Association of Pharmaceutical Scientists (AAPS) and the American Chemical Society (ACS). Through his academic directorship, impactful industrial ties, and transformative research, Dr. Douroumis continues to shape the future of pharmaceutical technology.